Linong Ji

机构：King University, Peking University, National Medical Products Administration, Peking University People's Hospital · ORCID：0000-0003-1305-1598

发表论文 415 篇 · 总被引 12927 次 · h-index 50

代表论文

• IGF-1R Inhibitor IBI311 for the Treatment of Active Thyroid Eye Disease in Chinese Patients (2025 · JAMA Ophthalmology · 被引 11)
• Addressing unmet needs for chronic kidney disease treatment in type 1 diabetes: A review (2025 · Diabetes Obesity and Metabolism · 被引 6)
• Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trial (2025 · Contemporary Clinical Trials · 被引 5)
• GRADE notes 6: Three strategies to determine the clinically important thresholds for outcomes in evidence-based guideline development (2025 · Journal of Clinical Epidemiology · 被引 5)
• Regional, age-specific and sex-specific trends in the prevalence of overweight or obesity in type 1 diabetes from 1980 to 2020: a meta-analysis of 78 observational studies with 650,265 participants (2025 · Diabetes Research and Clinical Practice · 被引 4)
• Heterogeneous Covariates-Aware Pseudo Supervised Meta-Learning for Few-Shot Diabetes Classification (2025 · IEEE Transactions on Computational Biology and Bioinformatics · 被引 2)